Cargando…
免疫检查点抑制剂相关心脏不良反应的临床诊治建议
Immunotherapy of malignant tumors has become a hot spot in the field of cancer research and treatment, bringing new hope to patients with advanced cancer. Activation of molecular programmer death protein-1 and T lymphocyte-associated antigen 4-related signaling pathways at the immunological checkpoi...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6817436/ https://www.ncbi.nlm.nih.gov/pubmed/31650944 http://dx.doi.org/10.3779/j.issn.1009-3419.2019.10.04 |
Ejemplares similares
-
免疫检查点抑制剂相关皮肤不良反应诊治建议
Publicado: (2019) -
免疫检查点抑制剂相关肾脏不良反应的临床诊治建议
Publicado: (2019) -
免疫检查点抑制剂相关内分泌不良反应的临床诊治建议
Publicado: (2019) -
免疫检查点抑制剂相关消化系统不良反应的临床诊治建议
Publicado: (2019) -
免疫检查点抑制剂相关神经系统不良反应的临床诊治建议
Publicado: (2019)